.jpeg?itok=Blt_FDOC)
Business Intelligence
Hear about new healthcare technology for improving patient and clinician experiences, and visit one of the most popular booths, where attendees stood in line to get some "puppy love,” all from the HIMSS23 exhibit hall.
While sharing insights on the medical device industry in China at HIMSS23, David Chen, director of business development for Shine Technology, stresses the importance of partnering to further new technologies.
It's crucial to pool resources to improve outcomes during times of crisis, says Dr. Monica Bharel, advanced clinical senior public health advisor and former commissioner of the Massachusetts Department of Public Health.
It's the place to be if you're interested and involved in transforming healthcare information and technology, says Ricardo Silva.
There are 13 startups from PharmaStars' cohort on digital innovation for women's health and health equity, and the accelerators' next cohort, Digital Innovations in Therapeutic Delivery. Naomi Fried, CEO and founder of PharmStars, offers a deep dive.
Clalit Chief Innovation Officer Ran Balicer speaks with HIMSS CEO Hal Wolf about the transformational potential of artificial intelligence for healthcare.
Open algorithms, explainable AI and thoughtful approaches to understanding and addressing the health equity of sub-cohorts end the legacy argument that AI is a "black box," says Andrew Eye, cofounder and CEO of ClosedLoop.ai.
HIMSS President & CEO Hal Wolf and Chair of the Board Directors Elena Sini discuss the details of HIMSS24 Europe in Rome 29-31 May 2024 and support from the HIMSS Italian community.
Dan Soule, VP of technology operations at Health Catalyst, reflected back on health equity 10 years ago and today's emergence of real-world uses for AI while attending his 50th HIMSS event.
The organization's new presence in Rotterdam builds from a memorandum of understanding with WHO-Europe and is a testament to HIMSS' commitment to the European healthcare ecosystem.
